Companies: 10,795·Total market cap: $144.5T
Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc.

ARCTNASDAQHealthcare● Active
$7.11
$-0.20(-2.67%)
Market Cap$201945905
P/E Ratio—
52W High$24.17
52W Low$5.85
SEC Filings

Arcturus Therapeutics Holdings Inc. (ARCT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001768224 · ARCT · NASDAQ · as of Jun 8, 2026

Filing snapshot

400
Total Filings
8-K
Latest Form
2026-06-05
Most Recent
2013
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001768224 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-03
Fiscal Year End
Mar 3, 2026
Accession No.
0001193125-26-088391
Primary Document
arct-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001768224 · Accession 0001193125-26-088391

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
Current Report
2026-06-05Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
Current Report
2026-06-05
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-07
View
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
Current Report
2026-05-07
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-07
View
DEF 14AProxy Statement
Proxy Statement
2026-04-24
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
10-KAnnual Report
10-K
2026-03-03
View
8-KCurrent Report
Current Report
2026-03-03
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-03
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-01-08
View
S-3Shelf Registration
Shelf Registration
2025-12-30
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2025-12-19
View
8-KCurrent Report
Current Report
2025-12-15
View
Showing 1–15 of 255 filingsForm 4 / 144 hidden· 400 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001768224  |  Exchange: NASDAQ · Healthcare

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has submitted 400 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2013. As a Healthcare sector company with CIK 0001768224, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Arcturus Therapeutics Holdings Inc.'s most comprehensive regulatory disclosure. The most recent Arcturus Therapeutics Holdings Inc. 10-K was filed on 2026-03-03 for fiscal year ending 2026. Historical ARCT 10-K annual reports are available from 2019 through 2026.

Investors researching Arcturus Therapeutics Holdings Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ACHV SEC Filings →VNDA SEC Filings →AVIR SEC Filings →TRDA SEC Filings →HUMA SEC Filings →ZURA SEC Filings →SGMT SEC Filings →FHTX SEC Filings →
→ ARCT Financials→ ARCT Earnings→ ARCT Insider Trades

Frequently Asked Questions

ARCT SEC Filings · 8 questions

Arcturus Therapeutics Holdings Inc. (ARCT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 400 filings and access original documents at no cost. Arcturus Therapeutics Holdings Inc.'s CIK is 0001768224.

ARCT SEC filingsArcturus Therapeutics Holdings Inc. SEC documentsfind ARCT 10-K